Study of plonmarlimab for frequent gout attacks
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Pain clinical trials.
This trial tests a new investigational drug called plonmarlimab for people with frequent, painful gout flares who cannot take standard treatments. The goal is to see if it can reduce pain and inflammation from the flare.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have had a gout flare in the last 5 days.
- You have had at least 3 gout flares in the last year.
- You cannot take or colchicine or NSAIDs (like ibuprofen) did not work for you.
- Your pain during the flare is at least 50 on a 0-100 scale (0=no pain, 100=worst pain).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, ABP-745, for people having an acute gout flare. It aims to see if the drug is safe and helps reduce pain and inflammation.
This trial tests an oral medication (HRS-2129) to see if it can calm a sudden gout flare and reduce joint pain. It may help if you are currently having a moderate-to-severe gout attack and are otherwise in good health.
This trial tests a new treatment called plamotamab for people with moderate to severe rheumatoid arthritis (RA) who have not had enough relief from current treatments. The goal is to see if it is safe and to help control RA symptoms.
This trial tests a new tablet called BR2251 for people with gout and high uric acid. It aims to lower uric acid levels and manage gout symptoms.
This study tests a new drug called IN026 for people with refractory gout—gout that doesn't respond well to current treatments and causes severe symptoms. The goal is to see if IN026 can lower uric acid levels and reduce gout attacks.
This trial tests a new medicine, PRX-115, given through a vein, to see if it lowers uric acid levels in people with gout who haven't had success with standard treatments. Some participants will also take methotrexate, and the results are compared to a placebo (a dummy infusion).
Hear when a new Acute Gouty Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.